New perspectives for gene therapy in endocrinology

被引:16
作者
Barzon, L
Bonaguro, R
Palù, G
Boscaro, M
机构
[1] Univ Padua, Dept Med & Surg Sci, I-35128 Padua, Italy
[2] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy
关键词
D O I
10.1530/eje.0.1430447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene therapy for endocrine diseases represents an exciting new type of molecular intervention that may be a curative one. Endocrine disorders that might be treated by gene therapy include monogenic diseases, such as GH deficiency and hypothalamic diabetes insipidus, and multifactorial diseases, such as diabetes mellitus, obesity and cancer. Premises seem promising for endocrine tumours, but many combined approaches of cell and gene therapy are foreseeable also for other endocrine disorders. This review outlines the principles of gene therapy, describes the endocrine disorders that might take advantage of gene transfer approaches, as well as the gene therapy interventions that have already been attempted, their major limitations and the problems that remain to be solved.
引用
收藏
页码:447 / 466
页数:20
相关论文
共 209 条
  • [1] Growth retardation - An unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts
    AlHendy, A
    Hortelano, G
    Tannenbaum, GS
    Chang, PL
    [J]. HUMAN GENE THERAPY, 1996, 7 (01) : 61 - 70
  • [2] CORRECTION OF THE GROWTH DEFECT IN DWARF MICE WITH NONAUTOLOGOUS MICROENCAPSULATED MYOBLASTS - AN ALTERNATE APPROACH TO SOMATIC GENE-THERAPY
    ALHENDY, A
    HORTELANO, G
    TANNENBAUM, GS
    CHANG, PL
    [J]. HUMAN GENE THERAPY, 1995, 6 (02) : 165 - 175
  • [3] Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
    Allison, J
    Georgiou, HM
    Strasser, A
    Vaux, DL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3943 - 3947
  • [4] Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine
    Anwer, K
    Shi, M
    French, MF
    Muller, SR
    Chen, W
    Liu, QS
    Proctor, BL
    Wang, JJ
    Mumper, RJ
    Singhal, A
    Rolland, AP
    Alila, HW
    [J]. HUMAN GENE THERAPY, 1998, 9 (05) : 659 - 670
  • [5] Balasa B, 1997, J IMMUNOL, V159, P4620
  • [6] Banerjee SK, 2000, INT J ONCOL, V16, P253
  • [7] BARZON L, 1999, END SOC 81 ANN M, P433
  • [8] Batteux F, 1999, EUR J IMMUNOL, V29, P958
  • [9] Batteux F, 1999, J IMMUNOL, V162, P603
  • [10] Sustained proliferation of PDX-1+ cells derived from human islets
    Beattie, GM
    Itkin-Ansari, P
    Cirulli, V
    Leibowitz, G
    Lopez, AD
    Bossie, S
    Mally, MI
    Levine, F
    Hayek, A
    [J]. DIABETES, 1999, 48 (05) : 1013 - 1019